[HTML][HTML] Clonally expanded T cells in T cell large granular lymphocytic leukaemia and immune-mediated arthritis
D Bhattacharya - 2023 - helda.helsinki.fi
T cell large granular lymphocytic leukaemia (T-LGLL) is a rare type of leukaemia. It is a
lymphoproliferative disorder that leads to clonal expansion of cytotoxic T cells in the blood …
lymphoproliferative disorder that leads to clonal expansion of cytotoxic T cells in the blood …
The unexpected localization of PAD4 in monocytes: implications for rheumatoid arthritis pathogenesis
MA Thomas - 2023 - jscholarship.library.jhu.edu
Although anti-citrullinated protein autoantibodies (ACPAs) are a hallmark serological feature
of rheumatoid arthritis (RA), the mechanisms and cellular sources behind the generation of …
of rheumatoid arthritis (RA), the mechanisms and cellular sources behind the generation of …
A Multi-Omic Approach to Stratified Medicine in Rheumatoid Arthritis
K Goldmann - 2022 - qmro.qmul.ac.uk
Rheumatoid arthritis (RA) is a chronic, systemic, and progressive autoimmune disease
primarily affecting synovial joints. It is characterised by immune cell-infiltration, severe …
primarily affecting synovial joints. It is characterised by immune cell-infiltration, severe …
[HTML][HTML] 抗氨甲酰化蛋白抗体检测在类风湿关节炎中的意义
黄睿， 张宁 - 中国医科大学学报, 2019 - html.rhhz.net
目的探究类风湿关节炎(RA) 患者中检测血清抗氨甲酰化蛋白(CarP) 抗体的意义和应用价值.
方法选取我院风湿免疫科2014 年9 月至2015 年10 月收治的RA 初诊患者135 例(RA 组) …
方法选取我院风湿免疫科2014 年9 月至2015 年10 月收治的RA 初诊患者135 例(RA 组) …
Routineeinsatz von Leflunomid bei Rheumatoider Arthritis
G Weigt - 2023 - tud.qucosa.de
Abstract (DE) Die Rheumatoide Arthritis (RA) ist eine multifaktoriell bedingte
Autoimmunerkrankung, die durch entzündlichen Gelenksbefall charakterisiert ist. Unter …
Autoimmunerkrankung, die durch entzündlichen Gelenksbefall charakterisiert ist. Unter …
[图书][B] YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer: A Critical Therapeutic Target
B Bonavida - 2020 - books.google.com
YY1 Is Pivotal in the Control of the Pathogenesis and Drug Resistance of Cancer: A Critical
Therapeutic Target describes the current state-of-the-art of the transcription factor YY1 that is …
Therapeutic Target describes the current state-of-the-art of the transcription factor YY1 that is …
[引用][C] Routineeinsatz von Leflunomid bei Rheumatoider Arthritis: Wirksamkeit und unerwünschte Arzneimittelwirkungen in Monotherapie und Kombinationstherapie
G Weigt - 2022 - Dissertation, Dresden, Technische …
Clinical presentation of patients with early rheumatoid arthritis without rheumatoid factor and antibodies against citrullinated proteins-peptide
R Sepúlveda, DR Soto, U Mercado - Medicina Interna de México, 2022 - medigraphic.com
Objective: To compare the clinical presentation and 12-month follow-up of seronegative and
seropositive rheumatoid arthritis patients who met 2010 ACR/EULAR criteria. Materials and …
seropositive rheumatoid arthritis patients who met 2010 ACR/EULAR criteria. Materials and …
[PDF][PDF] The'oRAcle'Study: Identifying Predictors of Adverse Outcomes in Rheumatoid Arthritis
K Bechman - 2021 - kclpure.kcl.ac.uk
Rheumatoid Arthritis (RA) is an immune mediated inflammatory joint disease, primarily
affecting synovial tissue leading to joint damage and physical disability. The disease affects …
affecting synovial tissue leading to joint damage and physical disability. The disease affects …
[PDF][PDF] The Impact of Seropositivity on Bone Mineral Density in Rheumatoid Arthritis-A 3-year Prospective Observational Study
SF Yu, JF Chen, YC Chen, YW Wang, CY Hsu, HM Lai… - 2021 - pdfs.semanticscholar.org
The Impact of Seropositivity on Bone Mineral Density in Rheumatoid Arthritis - A 3-year
Prospective Observational Study Page 1 Page 1/16 The Impact of Seropositivity on Bone …
Prospective Observational Study Page 1 Page 1/16 The Impact of Seropositivity on Bone …